
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About
Privia Health Group Inc (PRVA)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: PRVA (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $30.35
1 Year Target Price $30.35
14 | Strong Buy |
5 | Buy |
2 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -47.71% | Avg. Invested days 20 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.68B USD | Price to earnings Ratio 183.33 | 1Y Target Price 30.35 |
Price to earnings Ratio 183.33 | 1Y Target Price 30.35 | ||
Volume (30-day avg) 21 | Beta 0.83 | 52 Weeks Range 16.47 - 26.09 | Updated Date 06/30/2025 |
52 Weeks Range 16.47 - 26.09 | Updated Date 06/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.12 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 0.87% | Operating Margin (TTM) 1.09% |
Management Effectiveness
Return on Assets (TTM) 1.21% | Return on Equity (TTM) 3.01% |
Valuation
Trailing PE 183.33 | Forward PE 42.02 | Enterprise Value 2218333220 | Price to Sales(TTM) 1.49 |
Enterprise Value 2218333220 | Price to Sales(TTM) 1.49 | ||
Enterprise Value to Revenue 1.23 | Enterprise Value to EBITDA 77.23 | Shares Outstanding 121920000 | Shares Floating 104153399 |
Shares Outstanding 121920000 | Shares Floating 104153399 | ||
Percent Insiders 6.71 | Percent Institutions 100.2 |
Analyst Ratings
Rating 5 | Target Price 30.35 | Buy 5 | Strong Buy 14 |
Buy 5 | Strong Buy 14 | ||
Hold 2 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Privia Health Group Inc
Company Overview
History and Background
Privia Health Group Inc. was founded in 2007. It focuses on partnering with physician groups to improve healthcare delivery through technology and services. It went public in April 2021.
Core Business Areas
- Physician Enablement: Provides technology and services to help physician practices improve patient care, reduce costs, and enhance revenue.
- Value-Based Care: Participates in value-based care arrangements, such as accountable care organizations (ACOs), to share in savings generated by improved patient outcomes and cost efficiency.
Leadership and Structure
Shawn Gupta is the CEO. The company operates with a board of directors and a management team overseeing different functional areas, including operations, finance, and technology.
Top Products and Market Share
Key Offerings
- Privia Cloud: A proprietary technology platform that provides electronic health record (EHR), practice management, and analytics capabilities. Market share is difficult to pinpoint precisely, but Privia Cloud competes with established EHR vendors like Epic and Cerner (Oracle Health). Revenue attributable to this product is not explicitly broken out. Competitors: Epic, Oracle Health (Cerner), athenahealth.
- Privia Medical Groups: Physician practices operating under the Privia brand. Revenue is generated from patient care services and value-based care arrangements. The precise revenue split is not publicly disclosed. Competitors: OptumCare, UnitedHealth Group (through OptumCare), other independent physician associations (IPAs).
Market Dynamics
Industry Overview
The healthcare industry is undergoing a shift towards value-based care, with increasing emphasis on improving patient outcomes and reducing costs. Digital health solutions and physician enablement services are growing areas.
Positioning
Privia Health Group Inc. is positioned as a physician enablement company that helps independent physician practices transition to value-based care. Its competitive advantage lies in its technology platform and expertise in value-based care arrangements.
Total Addressable Market (TAM)
The TAM for physician enablement and value-based care is estimated to be in the tens of billions of dollars annually. Privia Health is positioned to capture a portion of this market through its services. Exact TAM data requires deeper industry report access.
Upturn SWOT Analysis
Strengths
- Proprietary technology platform (Privia Cloud)
- Expertise in value-based care arrangements
- Strong physician network
- Scalable business model
Weaknesses
- Reliance on physician adoption of its platform
- Competition from larger, more established healthcare companies
- Dependence on government regulations and reimbursement policies
- Relatively short operating history as a public company
Opportunities
- Expansion into new geographic markets
- Acquisition of smaller physician practices or technology companies
- Partnerships with hospitals and health systems
- Increased adoption of value-based care models
Threats
- Changes in healthcare regulations or reimbursement policies
- Increased competition from other physician enablement companies
- Cybersecurity risks
- Economic downturn
Competitors and Market Share
Key Competitors
- ATHN
- OTLK
- HUM
Competitive Landscape
Privia Health Group Inc. competes with a mix of established healthcare technology companies and other physician enablement providers. Its advantage lies in its focus on value-based care and its strong physician network. However, it faces competition from larger companies with greater resources.
Growth Trajectory and Initiatives
Historical Growth: Historical growth data is not included due to inability to access external information and adhere to data recency requirements.
Future Projections: Future growth projections are not included due to inability to access external information and adhere to data recency requirements.
Recent Initiatives: Privia Health Group Inc. has been focused on expanding its physician network and enhancing its technology platform. It is also actively pursuing partnerships with other healthcare organizations.
Summary
Privia Health demonstrates promise through its physician enablement model and emphasis on value-based care, underscored by its proprietary tech. However, reliance on physician adoption and regulatory changes present challenges. Expansion and strategic partnerships could bolster growth. Continued market competition remains a key factor to monitor.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Website
- Analyst Reports (unavailable for direct data integration)
- Industry News Sources
Disclaimers:
This analysis is based on publicly available information and general industry knowledge. It is not financial advice. Market share data is approximate and based on available information. Financial figures and projections are not current and are for illustrative purposes only.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Privia Health Group Inc
Exchange NASDAQ | Headquaters Arlington, VA, United States | ||
IPO Launch date 2021-04-28 | CEO & Director Mr. Parth Mehrotra | ||
Sector Healthcare | Industry Health Information Services | Full time employees 1140 | Website https://www.priviahealth.com |
Full time employees 1140 | Website https://www.priviahealth.com |
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. The company also operates accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.